Patient Leaflet Updated 23-Jun-2025 | Biogen Idec Ltd
Skyclarys 50mg Hard Capsules
Skyclarys 50 mg hard capsules
omaveloxolone
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What Skyclarys is and what it is used for
2. What you need to know before you take Skyclarys
3. How to take Skyclarys
4. Possible side effects
5. How to store Skyclarys
6. Contents of the pack and other information
Skyclarys contains the active substance omaveloxolone, which activates a specific protein, Nrf2, in your body.
Skyclarys is used to treat adults and adolescents who are at least 16 years of age who have Friedreich’s ataxia, a neurodegenerative movement disorder. Friedreich’s ataxia is a rare inherited disease that causes progressive damage to your nervous system and movement problems.
The protein called Nrf2 in your body has a key role in managing oxidative stress (a condition that can damage cells in your body) and has a protective role against neurodegenerative diseases. In patients with Friedreich’s ataxia, Nrf2 activity is reduced. Skyclarys activates Nrf2 so it can manage oxidative stress.
In a clinical trial patients treated with Skyclarys scored better on tests of neurological function than patients who were treated with an inactive substance.
Do not take Skyclarys if you are allergic to omaveloxolone or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor before taking Skyclarys:
Your doctor will check to see how well your liver is working and will check your cholesterol level before you start taking Skyclarys. Your doctor will also check your level of BNP (B-type natriuretic peptide, a blood test for heart problems) before you start taking Skyclarys.
Contact your doctor immediately if you have sudden weight gain, swelling of legs, ankles, or feet, or shortness of breath, which may be signs or symptoms of heart problems while taking Skyclarys. Your doctor will decide on treatment and whether Skyclarys should be continued.
Your doctor will be checking blood tests while you are taking Skyclarys. This will include liver blood tests to see how your liver is working while taking Skyclarys. Your doctor will decide on whether to discontinue Skyclarys if liver problems develop. Other blood tests that your doctor will do will check cholesterol and BNP after you start Skyclarys.
Tell your doctor if you have weight loss with Skyclarys.
Do not give Skyclarys to children and adolescents below the age of 16 years because it has not yet been studied in this group of patients.
Tell your doctor if you are taking, have recently taken, or might take any other medicines. This is because some medicines may affect the way Skyclarys works. Also, Skyclarys may affect the way some medicines work.
Certain medicines may increase the risk of side effects of Skyclarys by increasing the levels of Skyclarys in the blood. Some of these medicines include:
If your doctor prescribes one of these medicines, your dose of Skyclarys may be reduced to prevent side effects when taking both drugs at the same time.
Certain medicines may reduce how well Skyclarys works by decreasing the amount of Skyclarys in the blood. Some of these medicines include:
Skyclarys may reduce how well some other medicines work by decreasing the amount of these medicines in the blood. Some of these medicines include:
Talk to your doctor if you are taking any medicines, particularly those mentioned above, as they may affect the way Skyclarys or other medicines work.
Avoid eating grapefruit or grapefruit juice while taking Skyclarys.
You should not take Skyclarys if you are pregnant, think you may be pregnant, or are planning to have a baby. Tell your doctor immediately if you become pregnant while you are being treated with Skyclarys.
Using Skyclarys can reduce the effectiveness of hormonal birth control. You should use a different method of birth control, such as a non-hormonal IUD (intrauterine device) or barrier contraceptives such as condoms. A reliable method of birth control should be used during Skyclarys treatment and for 28 days after stopping treatment with Skyclarys. Talk to your doctor about the most suitable birth control for you.
Do not breast-feed your baby while you are being treated with Skyclarys. It is not known if this medicine passes into the breast milk.
Some patients may feel tired after taking this medicine. If you feel tired after taking Skyclarys, avoid driving and using machines.
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium free’.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
The recommended dose is 150 mg (3 capsules) once per day.
If you have problems with your liver, your doctor may decide to change the dose or not start treatment with Skyclarys.
Some medicines may cause side effects when taken at the same time as Skyclarys. If your doctor prescribes one of these medicines while you are taking Skyclarys, your doctor may reduce the dose of Skyclarys to prevent side effects when taking both drugs at the same time.
If you are sick after taking your usual dose, do not take replacement capsules. Take the capsules as usual the following day.
If you take more Skyclarys than your doctor prescribed, talk to a doctor immediately. Take this leaflet with you.
If you miss a dose of Skyclarys, take the next dose as usual the following day. Do not take a double dose to make up for a forgotten dose.
Do not stop taking this medicine unless your doctor tells you.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Talk to your doctor immediately if you have any of these side effects:
Very common (may affect more than 1 in 10 people)
If you have any of these side effects, talk to your doctor.
Based on your blood tests, your doctor may tell you that you have:
Your doctor will decide on treatment and whether Skyclarys should be continued.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme.
Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
If the capsule is opened and mixed with apple puree you must eat all the apple puree/medicine mixture immediately after making it. See section 3, Taking Skyclarys.
Do not use this medicine if you notice that the pack is damaged or shows signs of tampering.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Skyclarys 50 mg hard capsules are made of an opaque light green body imprinted with “RTA 408” in white ink and a blue cap imprinted with “50” in white ink.
Skyclarys 50 mg is available in a pack containing 90 hard capsules and in a pack of 3 bottles, each containing 90 hard capsules.
This leaflet was last revised in September 2024.
5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD, UK
0800 008 7401